PTPRC and dermatitis: An examination of type 1 skin inflammation induced by ovalbumin/complete Freund’s adjuvant (OVA/CFA) did not reveal a significant reduction in skin immunity (quantities of CD45+ cells, neutrophils, eosinophils, CD3+ T cells, CD8+ T cells, and regulatory T cells or neutrophil/eosinophil ratio) after nociceptor silencing or ablation (Supplemental Figure 5).